These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33704664)

  • 21. CD34 stem cell dose and development of extensive chronic graft-versus-host disease.
    Handgretinger R; Lang P; Klingebiel T; Niethammer D
    Blood; 2002 May; 99(10):3875-6; author reply 3876-7. PubMed ID: 12014372
    [No Abstract]   [Full Text] [Related]  

  • 22. [Relationship between cellular immune function during conditioning and graft rejection in patients with beta-thalassemia major].
    Hao WG; Huang SL; Sun X; Liu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1375-7. PubMed ID: 19620057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome.
    Skert C; Patriarca F; Sperotto A; Cerno M; Filì C; Zaja F; Stocchi R; Geromin A; Damiani D; Fanin R
    Haematologica; 2006 Feb; 91(2):258-61. PubMed ID: 16461315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recipient interferon-gamma 3/3 genotype contributes to the development of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Bogunia-Kubik K; Mlynarczewska A; Wysoczanska B; Lange A
    Haematologica; 2005 Mar; 90(3):425-6. PubMed ID: 15749687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic Stem Cell Transplantation in Children and Adolescents.
    Guilcher GM
    Pediatr Rev; 2016 Apr; 37(4):135-44; quiz 145. PubMed ID: 27037099
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patients.
    Caocci G; Baccoli R; Vacca A; Mastronuzzi A; Bertaina A; Piras E; Littera R; Locatelli F; Carcassi C; La Nasa G
    Exp Hematol; 2010 May; 38(5):426-33. PubMed ID: 20206661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan.
    Bernardo ME; Piras E; Vacca A; Giorgiani G; Zecca M; Bertaina A; Pagliara D; Contoli B; Pinto RM; Caocci G; Mastronuzzi A; La Nasa G; Locatelli F
    Blood; 2012 Jul; 120(2):473-6. PubMed ID: 22645178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
    Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
    Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-22 in the diagnosis of active chronic graft-versus-host disease in paediatric patients.
    Tumino M; Serafin V; Accordi B; Spadini S; Forest C; Cortese G; Lissandron V; Marzollo A; Basso G; Messina C
    Br J Haematol; 2015 Jan; 168(1):142-5. PubMed ID: 25098229
    [No Abstract]   [Full Text] [Related]  

  • 30. Factors influencing outcome and incidence of late complications in children who underwent allogeneic hematopoietic stem cell transplantation for hemoglobinopathy.
    Khalil A; Zaidman I; Elhasid R; Peretz-Nahum M; Futerman B; Ben-Arush M
    Pediatr Hematol Oncol; 2012 Nov; 29(8):694-703. PubMed ID: 23020512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hashimoto encephalopathy as manifestation of central nervous system chronic graft-versus-host disease after hematopoietic stem cell transplantation.
    Vicent MG; Cantarín V; Guerrero C; Molina B; Nieto M; López P; Iglesias MI; Díaz MA
    Pediatr Blood Cancer; 2019 Dec; 66(12):e28008. PubMed ID: 31535441
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of dermatology consultation on the care of children with chronic graft-versus-host disease of the skin.
    Garza-Mayers AC; Anderson LE; Yu J; Huang JT
    J Am Acad Dermatol; 2019 Aug; 81(2):627-629. PubMed ID: 30677461
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of graft-versus-host disease on the clinical outcome of allogeneic hematopoietic stem cell transplantation for non-malignant diseases.
    Umeda K; Imai K; Yanagimachi M; Yabe H; Kobayashi M; Takahashi Y; Kajiwara M; Yoshida N; Cho Y; Inoue M; Hashii Y; Atsuta Y; Morio T;
    Int J Hematol; 2020 Jun; 111(6):869-876. PubMed ID: 32052319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children.
    Kondo M; Kojima S; Horibe K; Kato K; Matsuyama T
    Bone Marrow Transplant; 2001 Apr; 27(7):727-30. PubMed ID: 11360113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
    Radujkovic A; Guglielmi C; Bergantini S; Iacobelli S; van Biezen A; Milojkovic D; Gratwohl A; Schattenberg AV; Verdonck LF; Niederwieser DW; de Witte T; Kröger N; Olavarria E;
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1230-6. PubMed ID: 25797175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapsing polymyositis in chronic graft versus host disease.
    Sharaf N; Prayson RA
    J Clin Neurosci; 2014 Nov; 21(11):1964-5. PubMed ID: 24980629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Graft- versus -host disease.
    Pereira AZ; Vigorito AC; Almeida AM; Candolo AA; Silva ACL; Brandão-Anjos AEP; Sá BL; Souza CLS; Castro Junior CG; Oliveira JSR; Barban JB; Mancilha EMB; Todaro J; Lopes LP; Macedo MCMA; Rodrigues M; Ribeiro PC; Silva RLD; Roberto TS; Rodrigues TCR; Colturato VAR; Paton EJA; Barros GMN; Almeida RDS; Moreira MCR; Flowers ME
    Einstein (Sao Paulo); 2020; 18():eAE4799. PubMed ID: 32215466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia.
    Lv M; Zhang X; Xu L; Wang Y; Yan C; Chen H; Chen Y; Han W; Wang F; Wang J; Liu K; Huang X; Mo X
    Front Med; 2019 Dec; 13(6):667-679. PubMed ID: 31512033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic PBPC transplantation: an effect on incidence and distribution of chronic graft-versus-host disease without long-term survival benefit?
    Snowden JA; Nivison-Smith I; Atkinson K; Fay K; Concannon A; Dodds A; Milliken S; Biggs J
    Bone Marrow Transplant; 2000 Jan; 25(1):119-20. PubMed ID: 10654027
    [No Abstract]   [Full Text] [Related]  

  • 40. Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.
    Horan JT; Liesveld JL; Fenton P; Blumberg N; Walters MC
    Bone Marrow Transplant; 2005 Jan; 35(2):171-7. PubMed ID: 15531901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.